Staphylococci, coagulase negative is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

MICROBIOLOGY

  • Coagulase-negative staphylococci (CoNS) are aerobic, Gram-positive coccus, occurring in clusters.
    • Predominantly found on skin and mucous membranes.
    • Heterogeneous group
    • Catalase positive but coagulase negative (S. aureus is coagulase positive).
  • Major pathogens:
    • S. epidermidis: colonies typically small, white-beige (about 1-2 mm in diameter).
    • S. haemolyticus:
    • S. lugdunensis:
    • Over forty recognized species of CoNS capable of causing human disease.
  • Many strains with propensity to produce biofilm, allowing for adherence to medical devices.
  • Susceptibility profile for CoNS:
    • Vancomycin (CLSI): MIC cutoffs
      • Sensitive: ≤ 4 mg/L
      • Intermediate: 8-26 mg/L
      • Resistant: ≥ 32 mg/L
      • Note: EUCAST states resistance is MIC > 4 mg/L
      • Vancomycin resistance usually due to cell-wall thickening mechanisms.
    • Oxacillin:
      • Sensitive: ≤ 0.25 mg/L
      • Resistant: > 0.5 mg/L
      • Note: for S. lugdunesis sensitive if ≤ 2 mg/L and resistant for 4 mg/L.
    • Usually resistant of penicillin and typically (80%) to methicillinor oxacillin.
      • mecA gene encodes for low-affinity penicillin-binding protein.
      • Resistance can be heterotypic, so usually like to see multiple isolates determined as susceptible to beta-lactams, as only a minority of isolates typically express resistance phenotypes.
    • Linezolid resistance described, but remains rare.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: September 3, 2016